Course
Effectiveness scored 58 due to absence of course-specific RCTs/meta-analyses on PubMed/Examine.com, despite moderate evidence for component strategies like exercise (meta-analysis of 41 RCTs, SMD=-0.44 for anxiety reduction) and digital mental health programs (32 RCTs, g=0.33 for depression). General neuroscience advice aligns with some studies but Amen's SPECT emphasis lacks validation (critiqued in reviews). Safety is perfect (100) as a non-physical product with no FDA issues or risks. Quality
Good (68/100) - Effectiveness scored 58 due to absence of course-specific RCTs/meta-analyses on PubMed/Examine.com, despite moderate evidence for component strategies like exercise (meta-analysis of 41 RCTs, SMD=-0.44 for anxiety reduction) and digital mental health programs (32 RCTs, g=0.33 for depression). General neuroscience advice aligns with some studies but Amen's SPECT emphasis lacks validation (critiqued in reviews). Safety is perfect (100) as a non-physical product with no FDA issues or risks. Quality at 55 reflects transparency in content delivery but deducts for no independent verification or outcome studies, proprietary nature. Overall 68 (58*0.6 + 100*0.25 + 55*0.15) rates Average: useful self-help potential but unproven vs. evidence-based therapies. No dosages to assess as non-supplement; value hinges on user's preference for Amen's style over free alternatives.